Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-19

Clinical Trial Update: XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM) [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports on XW014 in healthy subjects and patients with Type 2 diabetes mellitus; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XW014

Snippet

Sponsor: Sciwind Biosciences USA Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED